title: Expression of human papillomavirus 6b L1 protein in silkworm larvae and enhanced green fluorescent protein displaying on its virus-like particles.
abstract: Human papillomavirus (HPV) 6b L1 capsid protein was expressed using the Bombyx mori nucleopolyhedrovirus (BmNPV) bacmid expression system in silkworm larvae. Two constructs, full-length L1 (500 a.a) and C-terminal-deleted short L1 (479 a.a), and three PCR-manipulated antigenic loops at amino acids 55-56, 174-175, and 348-349 regions were incorporated with whole enhanced green fluorescent protein (EGFP). Expressed in full, short L1 proteins and variants were purified in heparin affinity column chromatography and confirmed by SDS-PAGE and western blot. The presence of self-assembled virus-like particles (VLPs) and EGFP incorporation on the surface of VLPs were confirmed by the observation of transmission electron and immunoelectron microscopies, respectively. HPV 6b L1 major capsid protein was successfully expressed in silkworm, and effective manipulation on the antigenic regions showed the path to versatile vaccine development based on HPV L1-VLPs.
authors: Laboratory of Biotechnology, Integrated Bioscience Section, Graduate School of Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka, 422-8529 Japan.
authors: Muthukutty
authors: M
authors: Palaniyandi
authors: Tatsuya
authors: T
authors: Kato
authors: Enoch Y
authors: EY
authors: Park
keywords: BmNPV bacmid; Human papillomavirus silkworm expression system; Virus-like particles
references: Mol Pharm. 2011 Feb 7;8(1):29-43
references: 21047140
references: J Virol Methods. 2007 Sep;144(1-2):91-7
references: 17543396
references: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1915-20
references: 10051569
references: Nat Struct Biol. 1997 May;4(5):413-20
references: 9145113
references: J Virol. 1997 Apr;71(4):2988-95
references: 9060658
references: Methods. 2006 Sep;40(1):60-5
references: 16997714
references: Mol Cancer Ther. 2008 May;7(5):1329-35
references: 18483320
references: Int J Med Microbiol. 2008 Jan;298(1-2):135-42
references: 17888729
references: Virol J. 2009 Jun 18;6:81
references: 19538743
references: FEMS Microbiol Lett. 2000 Aug 1;189(1):121-7
references: 10913877
references: Adv Drug Deliv Rev. 2012 Jun 15;64(9):811-25
references: 22285585
references: Virology. 2003 Apr 25;309(1):32-40
references: 12726724
references: Mol Cell. 2000 Mar;5(3):557-67
references: 10882140
references: J Biol Chem. 2007 Oct 26;282(43):31803-11
references: 17804402
references: Virus Res. 2006 Dec;122(1-2):154-63
references: 16938363
references: Curr Pharm Biotechnol. 2005 Feb;6(1):49-55
references: 15727555
references: Cancer Immunol Immunother. 2010 Nov;59(11):1685-96
references: 20652244
references: J Virol. 2009 Oct;83(19):10085-95
references: 19640991